Home > Boards > US OTC > Biotechs > Oxford BioMedica PLC (OXBDF)

Oxford Biomedica To Get Milestone Payment As Axovant

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
georgejjl Member Profile
 
Followed By 80
Posts 11,745
Boards Moderated 0
Alias Born 04/08/04
160x600 placeholder
georgejjl   Tuesday, 04/30/19 07:45:52 PM
Re: None
Post # of 753 
Quote:
Oxford Biomedica To Get Milestone Payment As Axovant Doses Patient LONDON (Alliance News) - Oxford Biomedica on Tuesday said that Axovant Gene Therapies Ltd has ...
Alliance News30 April, 2019 | 5:24PMEmail Form
LONDON (Alliance News) - Oxford Biomedica on Tuesday said that Axovant Gene Therapies Ltd has triggered a USD15 million milestone payment to the company.

Axovant has announced the dosing of the first patient of the second cohort in the Sunrise-PD phase two trial of AXO-Lenti-PD in Parkinson's disease patients, Oxford Biomedica said, which has triggered the payment to the London-listed firm under an agreement signed in June.

Up to six patients will be dosed in this second cohort, Oxford Biomedica said. To date, the patient has experienced no complications related to the surgery or to administration of the vector and has been discharged home as planned.

Oxford Biomedica shares closed down 0.1% at 697.073 pence on Tuesday.



http://www.morningstar.co.uk/uk/news/AN_1556641470134623300/oxford-biomedica-to-get-milestone-payment-as-axovant-doses-patient.aspx

Good luck and GOD bless,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist